Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis - Top_Commentaries - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Transformation of Lower-Grade Gliomas to Malignancy: The Role of Contrast Enhancement, Surgical Resection Extent, and Interval-Censored Analysis of Natural History

  • By

  • Baran Atli

  • Maximilian Wartha

  • Matthias Gmeiner

  • Martin Aichholzer

  • Serge Weis

  • Dominik Vorhauer

  • Helga Wagner

  • Tanja Hauer

  • Carlo Serra

  • Petra Böhm

  • Michael Sonnberger

  • Nico Stroh-Holly

  • Stefan Aspalter

  • Kathrin Aufschnaiter

  • Tobias Rossmann

  • Maria Gollwitzer

  • Jawed Ziai

  • Annette Leibetseder

  • Josef Pichler

  • Wolfgang Thomae

  • Christian Dorfer

  • Andreas Gruber

  • Harald Stefanits

  • Philip Rauch

  • September 22, 2026

Share

3 Topic Commentaries

Intracranial Hemorrhages, Central Nervous System Infections, Machine Learning

  • Dr. Jane Smith, MD, Neurocritical Care Physician, MD

    Assistant Professor of Neurology

    University Hospital of Critical Care Medicine

    “While high internal AUCs like 0.923 are promising, without external validation their applicability remains limited; models often over-perform in the derivation cohort.”

    [Source]
  • Dr. Li Wei, PhD, Data Scientist & Neuroscience Researcher, PhD

    Senior Research Fellow

    Institute for Brain Health Research

    “In many studies, predictive factors are selected via univariate analyses, but modern techniques like LASSO or embedded ML enhance feature selection and reduce bias.”

    [Source]
  • Dr. Maria Gonzalez, MPH, Infectious Disease Epidemiologist, MPH

    Public Health Policy Advisor

    National Stroke & Infection Control Coalition

    “Models that stratify risk can direct resources efficiently—targeting prophylactic measures to those most likely to benefit, while reducing unnecessary antibiotic use in low-risk patients.”

    [Source]

Original Source(s)

Related Content